CN101613358A - 头孢噻吩酸的制备方法 - Google Patents
头孢噻吩酸的制备方法 Download PDFInfo
- Publication number
- CN101613358A CN101613358A CN200910074960A CN200910074960A CN101613358A CN 101613358 A CN101613358 A CN 101613358A CN 200910074960 A CN200910074960 A CN 200910074960A CN 200910074960 A CN200910074960 A CN 200910074960A CN 101613358 A CN101613358 A CN 101613358A
- Authority
- CN
- China
- Prior art keywords
- aca
- haloalkane
- preparation
- add
- cephalothin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002253 acid Substances 0.000 title claims abstract description 28
- 229960000603 cefalotin Drugs 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 title abstract 2
- 238000006243 chemical reaction Methods 0.000 claims abstract description 57
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 45
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000003756 stirring Methods 0.000 claims abstract description 30
- 150000001350 alkyl halides Chemical class 0.000 claims abstract description 21
- 238000002444 silanisation Methods 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 12
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000012346 acetyl chloride Substances 0.000 claims abstract description 10
- 150000001263 acyl chlorides Chemical class 0.000 claims abstract description 8
- 239000008346 aqueous phase Substances 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 26
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 claims description 21
- 239000008213 purified water Substances 0.000 claims description 21
- 239000003513 alkali Substances 0.000 claims description 20
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 17
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 13
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 13
- 238000000354 decomposition reaction Methods 0.000 claims description 12
- 230000003301 hydrolyzing effect Effects 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 claims description 10
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Chemical compound C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 claims description 9
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 8
- 235000017550 sodium carbonate Nutrition 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 7
- 206010013786 Dry skin Diseases 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 claims description 4
- 229960002682 cefoxitin Drugs 0.000 claims description 4
- 239000005051 trimethylchlorosilane Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 12
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 4
- 239000002351 wastewater Substances 0.000 abstract description 3
- 238000004042 decolorization Methods 0.000 abstract 1
- 238000011017 operating method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 239000012065 filter cake Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 5
- 238000013019 agitation Methods 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Images
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100749601A CN101613358B (zh) | 2009-07-23 | 2009-07-23 | 头孢噻吩酸的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100749601A CN101613358B (zh) | 2009-07-23 | 2009-07-23 | 头孢噻吩酸的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101613358A true CN101613358A (zh) | 2009-12-30 |
CN101613358B CN101613358B (zh) | 2011-09-14 |
Family
ID=41493265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100749601A Expired - Fee Related CN101613358B (zh) | 2009-07-23 | 2009-07-23 | 头孢噻吩酸的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101613358B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101914105A (zh) * | 2010-08-24 | 2010-12-15 | 广东省石油化工研究院 | 一种头孢噻吩酸的制备方法 |
CN101979393A (zh) * | 2010-09-16 | 2011-02-23 | 苏州中联化学制药有限公司 | 一种由7-aca合成头孢噻吩酸的方法 |
CN102040614A (zh) * | 2010-09-21 | 2011-05-04 | 湖南永利化工股份有限公司 | 一种水相法头孢噻吩酸的生产方法 |
CN107793431A (zh) * | 2017-11-12 | 2018-03-13 | 王龙 | 一种头孢噻芬酸的制备方法 |
-
2009
- 2009-07-23 CN CN2009100749601A patent/CN101613358B/zh not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101914105A (zh) * | 2010-08-24 | 2010-12-15 | 广东省石油化工研究院 | 一种头孢噻吩酸的制备方法 |
CN101979393A (zh) * | 2010-09-16 | 2011-02-23 | 苏州中联化学制药有限公司 | 一种由7-aca合成头孢噻吩酸的方法 |
CN101979393B (zh) * | 2010-09-16 | 2012-02-29 | 苏州中联化学制药有限公司 | 一种由7-aca合成头孢噻吩酸的方法 |
CN102040614A (zh) * | 2010-09-21 | 2011-05-04 | 湖南永利化工股份有限公司 | 一种水相法头孢噻吩酸的生产方法 |
CN107793431A (zh) * | 2017-11-12 | 2018-03-13 | 王龙 | 一种头孢噻芬酸的制备方法 |
CN107793431B (zh) * | 2017-11-12 | 2021-08-24 | 江西裕康医药有限公司 | 一种头孢噻吩酸的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101613358B (zh) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102775364B (zh) | 一种交联剂三烯丙基异氰尿酸酯的制备方法 | |
CN101613358B (zh) | 头孢噻吩酸的制备方法 | |
CN104445124B (zh) | 一种应用超重力技术生产磷酸二氢钾的方法 | |
CN109232628A (zh) | 一种一锅法合成二氟草酸硼酸锂的方法 | |
EP2370586A2 (en) | Process for the preparation of a monovalent succinate salt | |
CN111004162B (zh) | 一种以三乙酰氧基硼氢化钠为还原剂制备l-硒代胱氨酸的方法及其装置 | |
CN102391291B (zh) | 一种头孢美唑酸的制备方法 | |
CN104193765A (zh) | 一种头孢克肟的合成方法 | |
CN101891773B (zh) | 一种l-核糖制备工艺 | |
CN101607967B (zh) | 头孢西丁酸的制备方法 | |
CN103508473B (zh) | 碳酸锂生产中净化除镁的自动控制方法 | |
CN101613367A (zh) | 三甲基乙氧基硅烷的制备方法 | |
CN105399768A (zh) | 一种制备n-正丁基硫代磷酰三胺的清洁生产工艺 | |
CN102321086B (zh) | 一种腺嘌呤的合成方法 | |
CN101429538B (zh) | 7-α-甲氧基-3-去乙酰基头孢噻吩苄星盐的制备方法 | |
CN103910759B (zh) | 乙氧甲酰基亚乙基三苯基膦的制备方法 | |
CN106520892B (zh) | 7-氨基-3-乙烯基头孢烷酸的制备方法 | |
CN108997377B (zh) | 一种e型7-atca的制备方法 | |
CN104310420B (zh) | 由三氟化硼-10制备硼-10酸的方法 | |
CN1940079B (zh) | 利用酵母细胞不对称合成(2s,3s)-2-苯甲酰氨甲基-3-羟基丁酸酯系列化合物 | |
CN110922417A (zh) | 一种头孢氨苄结晶母液回收方法 | |
CN102417527A (zh) | 一种合成三氯蔗糖-6-乙酯的方法 | |
CN103788112A (zh) | 一种苄基生物素脱苄制备生物素的方法 | |
CN100420697C (zh) | 一种制备蔗糖-6-有机酸酯的方法 | |
CN106046020B (zh) | 一种通过结晶作用纯化尼莫克汀的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: HEBEI JIUPAI PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: HEBEI JIUPAI PHARMACY CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 052165 Shijiazhuang economic and Technological Development Zone, the Three Gorges Road, Hebei Patentee after: Hebei Jiupai Pharmaceutical Co., Ltd. Address before: 052165 Shijiazhuang economic and Technological Development Zone, the Three Gorges Road, Hebei Patentee before: Hebei Jiupai Pharmacy Co., Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20091230 Assignee: HEBEI YIPIN PHARMACEUTICAL CO., LTD. Assignor: Hebei Jiupai Pharmaceutical Co., Ltd. Contract record no.: 2014130000053 Denomination of invention: Preparation method of cephalotin acid Granted publication date: 20110914 License type: Exclusive License Record date: 20140421 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: HEBEI YIPIN PHARMACEUTICAL CO., LTD. Assignor: Hebei Jiupai Pharmaceutical Co., Ltd. Contract record no.: 2014130000053 Date of cancellation: 20151223 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110914 Termination date: 20200723 |
|
CF01 | Termination of patent right due to non-payment of annual fee |